|
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer Clinical Trials Info presented on Clinical Trials Search is not intended to be a substitute for certified medical advice, visits or professional assistance using a real physician. We are not physicians. Always consult your dr. about Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer Clinical research trials and Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer health trials happen in many of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new drugs. The function of the studies / projects is to resolve particular human medical questions. Clinical trials are a popular manner for mDs, government agencies, and private sector corporations to discover remedies for all varieties of circumstances, like Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer. Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer Clinical Trials and other clinical trials allow volunteers to obtain healthcare treatment options before they are available to the masses. Some times the participants undergo professional assistance for free of charge, and occasionally they are paid for their time. Sometimes there is a cost for a Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer clinical trial. Human subjects often get the best healthcare available for their Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer condition. Dangers are a reality, however, and may include additional or frequent mD visits, healthcare dangers (potentially life-jeopardising), and/or the treatment being ineffectual. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer  Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
For Condition: stage 2 prostate cancer,psychosocial effects/treatment,Nutrition,stage 1 prostate cancer,Fatigue,Quality of Life,stage 1 breast cancer,stage 2 breast cancer,Depression
Status: No longer recruiting
Sponsor(s): Duke Comprehensive Cancer Center , National Cancer Institute (NCI)
Synopsis: RATIONALE: Telephone counseling by a nutritionist and a personal trainer may improve physical function and quality of life in patients who have early-stage breast cancer or prostate cancer. PURPOSE: Randomized clinical trial to compare the effectiveness of a home-based, diet and exercise-based counseling program with that of a standard home-based counseling program in promoting health in patients who have early-stage breast cancer or prostate cancer.
Details: OBJECTIVES: - Compare the efficacy of a diet and exercise-based home-based counseling program versus a standard home-based counseling program for improving physical function at 6 and 12 months for patients with early-stage breast or prostate cancer. - Compare the effects of these home-based programs on diet quality, physical activity, weight status, depression, and quality of life of these patients. - Compare the factors, such as gender, race, and social support, that interact with these home-based programs to predict program efficacy in these patients. OUTLINE: This is a randomized, multicenter study. Patients are randomized to 1 of 2 arms. - Arm I: Patients receive home-based telephone counseling by a personal nutritionist and a personal trainer. - Arm II: Patients receive home-based standard health telephone counseling in unrelated areas of cancer care (e.g., sun exposure, screening, and falls prevention). In both arms, counseling continues every 2 weeks for 6 months. Patients are followed at 6 months. PROJECTED ACCRUAL: A total of 420 patients (210 per arm) will be accrued for this study.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 65 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Diagnosis of early-stage breast or prostate cancer within the past 18 months - Dietary and physical activity habits and baseline functional status that places patient at risk - Potentially able to increase physical activity and to follow a low-fat, plant-based diet - Hormone receptor status: - Not specified PATIENT CHARACTERISTICS: Age: - 65 and over Sex: - Male or female Menopausal status: - Not specified Performance status: - Not specified Life expectancy: - Not specified Hematopoietic: - Not specified Hepatic: - Not specified Renal: - Not specified Other: - Able to speak and write English - No other malignancy within the past 5 years except nonmelanoma skin cancer - No other illness or condition that would preclude adherence to a plant-based diet or exercise PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - Not specified Radiotherapy: - Not specified Surgery: - Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
WendyDemark-Wahnefried, Study Chair, Duke Comprehensive Cancer Center
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710
United States
Additional Information:
Study ID Numbers: CDR0000069355; DUMC-1547-02-8R4ER,NCI-H02-0088,DUMC-1547-00-8R2ER
Study Start Date:
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00037024
Other Quality Of Life Studies:
1. Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer
2. Combination Chemotherapy in Treating Women With Resected Breast Cancer
3. Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
4. Tamoxifen in Treating Women With Breast Cancer
5. Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer
Related Studies:
Other Quality of Life Clinical Trials
Other North Carolina Clinical Trials
Other Durham Clinical Trials
Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
|
|
|
|
|
|
|
|
